NEW YORK – Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer (NYSE: PFE) COVID-19
1 year ago
On Monday, Bristol Myers Squibb (NYSE: BMY) won the dismissal of a $6.4 billion lawsuit claiming it cheated former Celgene
2seventy Bio (NASDAQ: TSVT) will discontinue enrolling patients in a late-stage study of its cell therapy Abecma, developed in partnership
Bristol-Myers Squibb (NYSE: BMY) stock jumped during intraday trading after the pharmaceutical giant announced strong second-quarter results and raised its
Bristol-Myers Squibb Company (NYSE: BMY) shares moved higher after the company issued better-than-expected adjusted earnings and revenue growth guidance for
2 years ago
